Champions Oncology Inc
NASDAQ:CSBR
Champions Oncology Inc
Cash from Investing Activities
Champions Oncology Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Champions Oncology Inc
NASDAQ:CSBR
|
Cash from Investing Activities
-$1.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-25%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Investing Activities
-$5.1B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-35%
|
|
Danaher Corp
NYSE:DHR
|
Cash from Investing Activities
-$7.1B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-18%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Investing Activities
-$131.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Investing Activities
-$301m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-3%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Investing Activities
-$1.6B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-21%
|
See Also
What is Champions Oncology Inc's Cash from Investing Activities?
Cash from Investing Activities
-1.7m
USD
Based on the financial report for Jan 31, 2024, Champions Oncology Inc's Cash from Investing Activities amounts to -1.7m USD.
What is Champions Oncology Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-25%
Over the last year, the Cash from Investing Activities growth was 35%. The average annual Cash from Investing Activities growth rates for Champions Oncology Inc have been 24% over the past three years , -14% over the past five years , and -25% over the past ten years .